Search: onr:"swepub:oai:DiVA.org:mau-5415" >
Targeted suppressio...
-
Sarwar, MartuzaLund University,Lunds universitet,Experimentell cancerforskning, Malmö,Forskargrupper vid Lunds universitet,Experimental Cancer Research, Malmö,Lund University Research Groups
(author)
Targeted suppression of AR-V7 using PIP5K1α inhibitor overcomes enzalutamide resistance in prostate cancer cells
- Article/chapterEnglish2016
Publisher, publication year, extent ...
-
2016-08-31
-
Impact Journals,2016
-
electronicrdacarrier
Numbers
-
LIBRIS-ID:oai:DiVA.org:mau-5415
-
https://urn.kb.se/resolve?urn=urn:nbn:se:mau:diva-5415URI
-
https://doi.org/10.18632/oncotarget.11757DOI
-
https://lup.lub.lu.se/record/c6f4b8b1-8a89-4df0-9e06-368b57eb49beURI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
One mechanism of resistance of prostate cancer (PCa) to enzalutamide (MDV3100) treatment is the increased expression of AR variants lacking the ligand binding-domain, the best characterized of which is AR-V7. We have previously reported that Phosphatidylinositol-4-phosphate 5-kinase alpha (PIP5Kα), is a lipid kinase that links to CDK1 and AR pathways. The discovery of PIP5Kα inhibitor highlight the potential of PIP5K1α as a drug target in PCa. In this study, we show that AR-V7 expression positively correlates with PIP5K1α in tumor specimens from PCa patients. Overexpression of AR-V7 increases PIP5K1α, promotes rapid growth of PCa in xenograft mice, whereas inhibition of PIP5K1α by its inhibitor ISA-2011B suppresses the growth and invasiveness of xenograft tumors overexpressing AR-V7. PIP5K1α is a key co-factor for both AR-V7 and AR, which are present as protein-protein complexes predominantly in the nucleus of PCa cells. In addition, PIP5K1α and CDK1 influence AR-V7 expression also through AKT-associated mechanism dependent on PTEN-status. ISA-2011B disrupts protein stabilization of AR-V7 which is dependent on PIP5K1α, leading to suppression of invasive growth of AR-V7-high tumors in xenograft mice. Our study suggests that combination of enzalutamide and PIP5K1α may have a significant impact on refining therapeutic strategies to circumvent resistance to antiandrogen therapies
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Semenas, JuliusUmeå University,Lund University,Lunds universitet,Experimentell cancerforskning, Malmö,Forskargrupper vid Lunds universitet,Experimental Cancer Research, Malmö,Lund University Research Groups(Swepub:lu)med-js4
(author)
-
Miftakhova, ReginaUmeå University,Lund University,Lunds universitet,Experimentell cancerforskning, Malmö,Forskargrupper vid Lunds universitet,Experimental Cancer Research, Malmö,Lund University Research Groups,Kazan Federal University(Swepub:lu)med-rem
(author)
-
Simoulis, AthanasiosDepartment of Clinical Pathology and Cytology, Skåne University Hospital, Malmö, Sweden
(author)
-
Robinson, BrianDepartment of Pathology, Weill Cornell Medical College, New York, NY, USA
(author)
-
Gjörloff Wingren, AnetteMalmö University,Malmö högskola,Institutionen för biomedicinsk vetenskap (BMV),Biofilms Research Center for Biointerfaces(Swepub:lu)mikr-agj
(author)
-
Mongan, Nigel PFaculty of Medicine and Health Sciences, School of Veterinary Medicine and Sciences, University of Nottingham, Nottingham, United Kingdom(Swepub:lu)med-ngm
(author)
-
Heery, DavidSchool of Pharmacy, University of Nottingham, Nottingham, United Kingdom
(author)
-
Johnsson, HeatherDepartment of Bio-Diagnosis, Beijing Institute of Basic Medical Sciences, Beijing, China
(author)
-
Abrahamsson, Per-AndersLund University,Lunds universitet,Urologi, Malmö (Abrahamsson),Forskargrupper vid Lunds universitet,Urological research, Malmö,Lund University Research Groups(Swepub:lu)uro-paa
(author)
-
Dizeyi, NishtmanLund University,Lunds universitet,Urologi, Malmö (Abrahamsson),Forskargrupper vid Lunds universitet,Urological research, Malmö,Lund University Research Groups(Swepub:lu)kir-dni
(author)
-
Luo, JonDepartment of Urology, the James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA
(author)
-
Persson, Jenny LUmeå University,Lund University,Lunds universitet,Experimentell cancerforskning, Malmö,Forskargrupper vid Lunds universitet,Experimental Cancer Research, Malmö,Lund University Research Groups(Swepub:lu)medk-jpe
(author)
-
Experimentell cancerforskning, MalmöForskargrupper vid Lunds universitet
(creator_code:org_t)
Related titles
-
In:Oncotarget: Impact Journals7:39, s. 63065-630811949-2553
Internet link
Find in a library
-
Oncotarget
(Search for host publication in LIBRIS)
To the university's database
- By the author/editor
-
Sarwar, Martuza
-
Semenas, Julius
-
Miftakhova, Regi ...
-
Simoulis, Athana ...
-
Robinson, Brian
-
Gjörloff Wingren ...
-
show more...
-
Mongan, Nigel P
-
Heery, David
-
Johnsson, Heathe ...
-
Abrahamsson, Per ...
-
Dizeyi, Nishtman
-
Luo, Jon
-
Persson, Jenny L
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Cancer and Oncol ...
- Articles in the publication
-
Oncotarget
- By the university
-
Malmö University
-
Lund University